 |
Corporate
Scientists / Advisors
David Ginsburg, M.D.
Dr. Ginsburg is a James V. Neel Distinguished University Professor of Internal Medicine and Human Genetics, a Warner-Lambert/Parke-Davis Professor of Medicine, and a member of the Life Sciences Institute at the University of Michigan Medical School. He received his B.A. degree in molecular biophysics and biochemistry from Yale University and his M.D. degree from Duke University School of Medicine. His postdoctoral clinical and research training was done at the Brigham and Women's Hospital and Children's Hospital, Harvard Medical School. Dr. Ginsburg is a member of the National Academy of Sciences, the Institute of Medicine, the American Academy of Arts and Sciences, and recipient of the E. Donnall Thomas Lecture and Prize from the American Society of Hematology, the Basic Research Prize from the American Heart Association, and the 2004 ASCI Award from the American Society of Clinical Investigation. Dr. Ginsburg is interested in understanding the components of the blood-clotting system and how disturbances in their function lead to human bleeding and blood-clotting disorders.
RETURN TO TOP
Sanford (Sandy) D. Markowitz, M.D., Ph.D.
Dr. Markowitz is Ingalls Professor of Cancer Genetics in the Department of Medicine (Hematology-Oncology) and the Ireland Cancer Center, with co-appointment in the Department of Molecular Biology, at Case Western Reserve University School of Medicine and an attending physician at University Hospitals of Cleveland. He received his B.A. degree in physics and chemistry from Harvard University. He received his M.D. and his Ph.D. degree in cell biology from Yale University where he worked with Vincent Marchesi. Dr. Markowitz completed clinical training in internal medicine at the University of Chicago and in medical oncology at the National Cancer Institute. He did his postdoctoral research at NCI in the laboratory of John Minna.
RETURN TO TOP
Alan F. Schatzberg, M.D.
Alan F. Schatzberg received his M.D. from New York University and did his psychiatric residency at the Massachusetts Mental Health Center and a Clinical Fellow in Psychiatry at Harvard Medical School. After serving in the Air Force, Dr. Schatzberg joined the staff at McLean Hospital and the Faculty of Harvard Medical School. In 1988, he became Clinical Director of the Massachusetts Mental Health Center and Professor of Psychiatry at Harvard Medical School. In 1991, Dr. Schatzberg moved to Stanford University to become the Kenneth T. Norris, Jr., Professor and Chairman of the Department of Psychiatry and Behavioral Sciences. Dr. Schatzberg has authored and edited numerous publications including the Manual of Clinical Psychopharmacology and the Textbook of Psychopharmacology. He is Co-Editor-in-Chief of the Journal of Psychiatric Research and sits on many other editorial boards. He was awarded the Gerald L. Klerman, MD Lifetime Research Award from the NDMDA, the Gerald L. Klerman, MD Award from Cornell University Medical College, the Edward A. Strecker, MD Award from the University of Pennsylvania, the Mood Disorders Research Award from the American College of Psychiatrists, the American Psychiatric Association Award for Research, the Forum Award from the 3rd International Forum of Mood and Anxiety Disorders (IFMAD), and the Distinguished Service in Psychiatry Award from the American College of Psychiatrists. In 2003, he was elected into the Institute of Medicine of the National Academy of Sciences.
RETURN TO TOP
Milenko Tanasijevic, M.D., M.B.A.
Dr. Tanasijevic is the Director Clinical Laboratories and Clinical Program Development of the Department of Pathology of Brigham and Women's Hospital and Dana Farber Cancer Institute, and an Associate Professor of Pathology at the Harvard Medical School. Dr. Tanasijevic is also a member of the Senior Management Team of Brigham and Women's Hospital. He oversees the operation of the clinical laboratories, performing over 8 MM tests annually, and he is responsible for coordination of translation research, advanced diagnostics, and program and business development. His research interests include cardiac biomarkers, laboratory informatics, tumor markers and fetal lung maturity testing. Dr. Tanasijevic is the Chairman of the American Society of Clinical Pathology Expert Review Panel. He serves on the Editorial Board of the American Journal of Clinical Pathology and the Journal of Thrombosis and Thrombolysis.
RETURN TO TOP
Stephen G. Young, M.D.
Dr. Young graduated from Princeton University in 1974 and then attended Washington University School of Medicine, obtaining an M.D. degree in 1978. After graduating from medical school he completed training in internal medicine and cardiovascular diseases at UCSF and UCSD, respectively and he is currently board-certified in both disciplines. After clinical training, Dr. Young obtained additional clinical training in lipidology and research training in the molecular genetics of lipid disorders. Dr. Young joined the medical school faculty at UCSD in 1985, but then moved to UCSF in 1986, advancing to the rank of professor by 1995. After 18 years at UCSF, Dr. Young was recruited to the Department of Medicine at UCLA, joining a highly respected team of investigators in the area of lipid metabolism and atherosclerosis. He is a member of the American Society for Clinical Investigation and the Association of American Physicians, and serves on the editorial board of multiple scientific journals. Dr. Young's laboratory is funded by the National Institutes of Health for several projects, including the development of knockout mouse models, the study of protein post-translational modifications as they related to cancer therapy and aging, and atherosclerosis and lipid metabolism.
RETURN TO TOP
|
|
